Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Two aviation ETFs pull in opposite directions: JETS targets airlines and airports, ITA leans into defense and aerospa...
NBCUniversal has reported a record-setting production cost for a 2022 blockbuster, surpassing Disney’s previous budge...
Meme coins began as jokes, yet a few have established serious market presence. This guide analyzes whether meme coins...
In June, Netflix faced a sharp pullback as investors weighed slowing subscriber growth against rising content costs a...
Argentina unveils an investment citizenship program aimed at foreign investors, signaling a bid to become a migration...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
The SEC and CFTC announced a formal partnership to harmonize crypto regulation and pursue new digital asset products....
Nvidia is facing a mixed start to 2026, but the long-term case remains intact. This article explains why a 40% jump b...
Gas prices have been volatile, but a single factor sets the pace at the pump. This reader-friendly guide explains the...
Palantir stock just popped on fresh bullish whispers and government momentum. This guide breaks down the drivers, ris...